title: Oligonucleotides and oligonucleotide conjugates: a new approach for cancer treatment.
abstract: In this account we summarise recent studies on oligonucleotides and oligonucleotide derivatives and their utilisation in antigene, antisense and decoy approaches, with particular attention to peptide nucleic acids, locked nucleic acids and oligonucleotide conjugates, the most promising compounds in this field.
authors.affiliation: Dipartimento di Scienze Farmaceutiche, Università degli Studi di Trieste, Piazzale Europa 1, I-34127 Trieste, Italy.
authors.forename: Tatiana
authors.initials: T
authors.lastname: Da Ros
authors.forename: Giampiero
authors.initials: G
authors.lastname: Spalluto
authors.forename: Maurizio
authors.initials: M
authors.lastname: Prato
authors.forename: Tula
authors.initials: T
authors.lastname: Saison-Behmoaras
authors.forename: Alexandre
authors.initials: A
authors.lastname: Boutorine
authors.forename: Barbara
authors.initials: B
authors.lastname: Cacciari
mesh_terms: D024221:Antineoplastic Protocols; D003432:Cross-Linking Reagents / Q000737:chemistry*; D006801:Humans; D008968:Molecular Conformation; D009369:Neoplasms / Q000188:drug therapy*; D009696:Nucleic Acids / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D009841:Oligonucleotides / Q000737:chemistry / Q000627:therapeutic use*; D016376:Oligonucleotides, Antisense / Q000737:chemistry / Q000627:therapeutic use
chemical_list: D003432:Cross-Linking Reagents; D009696:Nucleic Acids; D009841:Oligonucleotides; D016376:Oligonucleotides, Antisense